Illumina, Inc. ILMN has received approval from Japan’s Ministry of Health, Labour and Welfare for TruSightTM Oncology (TSO) Comprehensive for Class III/IV Medical Device (Specially Controlled Medical ...
BOSTON, May 30, 2025 /PRNewswire/ -- Velsera announces that its clinical Knowledgebase is powering the interpretation framework behind Illumina's TruSight™ Oncology Comprehensive (TSO Comp) assay, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback